Sourcing Exosomes in Washington

ExaVeyra ships to licensed practices in all 50 states, Washington included. Distribution-side licensing is the supplier’s obligation rather than the purchasing practice’s, so your practice orders against its own professional license and NPI, and ExaVeyra confirms the destination-specific licensure of its supply chain before a first order ships. What changes state to state is how the state regulates who performs a procedure and what notices a practice must give, while federal law governs the product itself.

What your practice provides

• An active Washington professional license in good standing, verifiable through the Department of Health’s provider credential search.
• A valid NPI, which ExaVeyra verifies at account setup.
• A signed research-use acknowledgment on file for exosome material.
• A Washington reseller permit from the Department of Revenue if the practice is purchasing for resale rather than for use in its own operations. Every business selling at wholesale must hold a copy of the buyer’s permit, so ExaVeyra asks for it at setup.

How the state permits wholesale distribution

Washington licenses the out-of-state supplier on two tracks, both through the Pharmacy Quality Assurance Commission. RCW 18.64.360 defines a nonresident pharmacy as any pharmacy located outside the state that ships, mails or delivers controlled substances, legend drugs or devices into Washington; it must be licensed by the Department of Health, disclose its owners and dispensing pharmacists, designate a Washington resident agent, and submit an inspection report issued within two years of application or renewal. RCW 18.64.046 requires a wholesaler’s license of any person, in or outside Washington, who sells legend drugs and nonprescription drugs at wholesale to pharmacies and practitioners in the state. WAC 246-945-100 holds every commission licensee that compounds sterile or nonsterile preparations, for patient administration or for distribution to a licensed practitioner, to USP chapters 795, 797, 800 and 825. Each license sits with the supplier, not with the purchasing practice.

RCW 18.64.360; RCW 18.64.046; WAC 246-945-100 · Washington State Department of Health, Pharmacy Quality Assurance Commission

Washington runs on two models. A physician-led practice delegates nonsurgical cosmetic procedures under WAC 246-919-606, which requires the delegating physician to be trained in the procedure, a written office protocol naming the responsible physician and the patient selection criteria, a signed patient consent that identifies the delegate, and documentation of each treatment in the patient’s record. An ARNP-led practice orders and supervises within nursing scope on its own authority. Either way, the Department of Health’s guidance places responsibility for keeping every person inside their legal scope on the medical director or supervisor.

Good faith examination

Washington does not use the phrase “good faith examination” in statute or rule. The functional requirement sits in the delegation rule: a physician-led practice’s written office protocol must include selection criteria to screen patients for the appropriateness of treatment, the physician must be trained in the procedure, and each treatment is documented in the patient’s medical record. An ARNP may perform the examination and set the plan within their own scope. Confirm current expectations with the Washington Medical Commission and the Washington State Board of Nursing.

Ownership and clinic licensing

Washington has no statute expressly prohibiting the corporate practice of medicine; the doctrine rests on case law, and the Department of Health’s own guidance for businesses offering esthetic services lists it among the legal issues to consider, alongside fee-splitting, rebating and aiding unlicensed practice, and recommends counsel. Advanced registered nurse practitioners hold independent practice authority, so an ARNP-led practice can operate within nursing scope, while a physician-led practice runs on physician delegation. Structure the entity with Washington counsel before opening.